Use Medical Affairs Management to innovate processes, allocate resources and to prove the strategic value and overall necessity of medical affairs.
Master investigator-initiated trial management practices while upholding transparency requirements. Build an IIT budget and ensure FMV compliance.
Stay compliant and keep pace with the rapid, worldwide formalization of FMV processes and legislation. Smart management depends on three key points — standardized rate cards, clear KOL scoring systems and regular access to reliable FMV rates — and this report covers all three.
Prove value for medical science liaisons with key metrics and analysis, set MSL compensation, structure MSL teams and refine medical strategy.
Set call center strategies and tactics with the most important key performance indicators (KPIs) and benchmarks that demonstrate medical information value.
Transparency is of growing importance to both the pharmaceutical industry and scientific community. New methods - open access journals, online portals - have emerged that help companies publish their clinical data. This report is a detailed benchmarking study of current medical publications team structures and strategies.
This report provides data benchmarks for setting fair-market value compensation for healthcare providers in the Middle East. The best practices and strategic insights are gathered from top pharmaceutical companies operating in the region and provide guidance for establishing FMV protocols and procedures at the country-level.
Use this report's detailed data and best practices on pharmaceutical advisory boards to recruit the ideal ad board participants, establish clear protocols to create actionable deliverables and use participant feedback to drive improvements and build relationships with key players.
Learn strategies for building an efficient HOL team and discover best practices to get the best results out of payer interactions.
Examine pharmaceutical thought leader management team structures, staffing and budgets. Benchmark pharmaceutical key opinion leader segments for the top three pharma thought leader tiers, five company sizes and 26 therapeutic areas.
Adapt educational speaker program teams, recruitment practices and event management to coming regulatory changes under the Sunshine Act.
Design and execute Phase IV (4) clinical trials with trial timelines, budget benchmarks, and breakdowns of trial management and strategy.
Strengthen your diabetes Medical Science Liaison team with hard-to-find data on budgets, staffing, field activities and compensation.